Trial to Increase FEP Attendance
Financial Incentives to Increase Treatment Attendance in First-Episode Psychosis Care: A Non-Randomized, Adaptive Pilot Study
Sponsor: Penn Innovation in Suicide Prevention for Implementation Research (INSPIRE) Center
This EARLY_PHASE1 trial investigates First-Episode Psychosis and is currently ongoing. Penn Innovation in Suicide Prevention for Implementation Research (INSPIRE) Center leads this study, which shows 13 recorded versions since 2025 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
13 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting EARLY_PHASE1
-
Jan 2026 — Feb 2026 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Jun 2025 — Jan 2026 [monthly]
Recruiting EARLY_PHASE1
-
Apr 2025 — Jun 2025 [monthly]
Recruiting EARLY_PHASE1
-
Feb 2025 — Apr 2025 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
▶ Show 8 earlier versions
-
Dec 2024 — Feb 2025 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Oct 2024 — Dec 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Apr 2024 — Jul 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Feb 2024 — Apr 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Nov 2023 — Feb 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Sep 2023 — Nov 2023 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Penn Innovation in Suicide Prevention for Implementation Research (INSPIRE) Center
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .